Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Aug 27, 2024; 16(8): 2528-2537
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2528
Table 1 Clinicopathological characteristics

LSR group
Control group
Value of statisticsP value
n = 20
n = 18
Age (year)67.00 ± 9.1166.89 ± 9.46t = 0.0370.971
Sex, n (%)F1.000
Male14 (70.0)13 (72.2)
Female6 (30.0)5 (27.8)
Body mass index (kg/m2)23.19 ± 3.8122.45 ± 3.62t = 0.6190.540
Distance of the tumor from the anal verge (cm)3.00 (2.00, 4.00)3.75 (3.00, 4.00)z = 1.6340.102
Tumor size (cm)4.25 (3.58, 4.25)4.00 (3.00, 6.00)z = 0.2660.791
Neoadjuvant therapy, n (%)F0.606
Yes3 (15.0)1 (5.6)
No17 (85.0)17 (94.4)
Clinical stage, n (%)χ2 = 1.8260.401
I5 (25.0)8 (44.4)
II9 (45.0)5 (27.8)
III6 (30.0)5 (27.8)
IV0 (0.0)0 (0.0)
Preoperative comorbidities, n (%)-0.516
Yes12 (60.0)8 (44.4)
No8 (40.0)10 (55.6)
Preoperative hemoglobin114.05 ± 17.18120.89 ± 16.26t = 1.2570.217
Preoperative prealbumin256.40 ± 67.50227.18 ± 59.39t = 1.4100.167